Drug intelligence / Profile preview

pleuran

Development stage
Unknown
Lead developer
Pleuran
Administration
Oral
01

Overview

Pleuran is an insoluble polysaccharide classified as a β-(1,3/1,6)-D-glucan and is isolated from the mushroom Pleurotus ostreatus. It belongs to the group of glucose polymers known as beta-glucans and acts as a biological response modifier with immunomodulating properties. Pleuran exerts its effects by binding to glycoprotein receptors such as Dectin-1, TLRs (Toll-like receptors), and Complement receptor 3 (CR3) on immune cells including macrophages, monocytes, dendritic cells, and natural killer (NK) cells. This interaction stimulates both innate and adaptive immune responses through increased phagocytic activity and production of pro-inflammatory cytokines like tumor necrosis factor alpha (TNF-α), interleukin 2 (IL-2), IL-10, IL-12, IL-6, IL-8, complement components, eicosanoids among others. These actions enhance resistance to infections by supporting humoral immunity via B lymphocyte mobilization and boosting cellular immunity through NK cell activation. Clinically studied for reducing duration/severity of acute gastroenteritis in children[1], lowering incidence/duration of upper respiratory tract infections[2][5], preventing exercise-induced immune suppression[5], managing bacterial exacerbations in COPD[2][7], and showing promise in acute herpes simplex virus type 1 infection[4]. No significant side effects have been reported in clinical trials.

Other names
β-(1,3/1,6)-D-glucanbeta-glucan from Pleurotus ostreatus
02

Targets

αMβ2 (Integrin αMβ2)CLEC7A (Dectin-1)TLR (Toll-like receptors)

Beyond the preview

Go deeper on pleuran.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pleuran.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call